Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2015, Article ID 547023, 3 pages
http://dx.doi.org/10.1155/2015/547023
Case Report

Systemic Levamisole-Induced Vasculitis in a Cocaine User without Cutaneous Findings: A Consideration in Diagnosis

1Department of Medicine, Emory University, Atlanta, GA 30308, USA
2Division of Renal Medicine, Department of Medicine, Emory University, Atlanta, GA 30308, USA
3Division of Hospital Medicine, Department of Medicine, Emory University, Atlanta, GA 30308, USA

Received 12 August 2015; Revised 22 September 2015; Accepted 27 September 2015

Academic Editor: Masahiro Kohzuki

Copyright © 2015 Gillian G. Baptiste et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Chang, J. Osterloh, and J. Thomas, “Levamisole: a dangerous new cocaine adulterant,” Clinical Pharmacology and Therapeutics, vol. 88, no. 3, pp. 408–411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. N. M. G. Walsh, P. J. Green, R. W. Burlingame, S. Pasternak, and J. G. Hanly, “Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole,” Journal of Cutaneous Pathology, vol. 37, no. 12, pp. 1212–1219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Pearson, M. Bremmer, J. Cohen, and M. Driscoll, “Vasculopathy related to cocaine adulterated with levamisole: a review of the literature,” Dermatology Online Journal, vol. 18, no. 7, article 1, 2014, http://escholarship.org/uc/item/6g18r9cv. View at Google Scholar
  4. L. Geller, T. Whang, S. Mercer, and R. Phelps, “Retiform purpura: a new stigmata of illicit drug use?” Dermatology Online Journal, vol. 17, no. 2, article 7, 2011. View at Google Scholar
  5. S. H. Poon, C. R. Baliog, R. N. Sams, L. Robinson-Bostom, G. H. Telang, and A. M. Reginato, “Syndrome of cocaine-levamisole-induced cutaneous vasculitis and immune-mediated leukopenia,” Seminars in Arthritis and Rheumatism, vol. 41, no. 3, pp. 434–444, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Wojciechowski, B. Kallakury, and P. Nouri, “A case of cocaine-induced acute interstitial nephritis,” American Journal of Kidney Diseases, vol. 52, no. 4, pp. 792–795, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Graf, K. Lynch, C.-L. Yeh et al., “Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine,” Arthritis and Rheumatism, vol. 63, no. 12, pp. 3998–4001, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. M. McGrath, T. Isakova, H. G. Rennke, A. M. Mottola, K. A. Laliberte, and J. L. Niles, “Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 12, pp. 2799–2805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Kouassi, G. Caille, L. Lery, L. Larivière, and M. Vézina, “Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine,” Biopharmaceutics and Drug Disposition, vol. 7, no. 1, pp. 71–89, 1986. View at Publisher · View at Google Scholar · View at Scopus
  10. R. L. Gross, J. Brucker, A. Bahce-Altuntas et al., “A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine,” Clinical Rheumatology, vol. 30, no. 10, pp. 1385–1392, 2011. View at Publisher · View at Google Scholar · View at Scopus